News
New York Has Lowest Risk For Employment Recruiting: Aon Hewitt
New York is the lowest risk city in the world for recruiting, employing and relocating employees, according to rankings released by Aon Hewitt, the global human resources business of Aon plc. This is ...SEC Approves But UBS Unhappy with Nasdaq Payback on Facebook IPO
U.S. regulators approved Nasdaq OMX Group's $62 million compensation plan for firms that lost money in Facebook Inc.'s glitch-ridden market debut, a victory for the exchange operator that also set ...
In North America, the World Cup is in full swing. With it, we can draw lessons from AI and contextual...
Cat Modeling Exec Keogh Joins TigerRisk
TigerRisk Partners, a reinsurance broking and risk/capital management firm, announced that William (Bill) Keogh, will become a member of the company's Decision Support Team. Keogh comes to TigerRisk ...PartnerRe Ltd. Launches Lorenz Re Sidecar
PartnerRe Ltd. has formed Lorenz Re Ltd., a special purpose insurer domiciled in Bermuda. PartnerRe said the vehicle provide additional capacity to PartnerRe on a diversified portfolio of catastrophe ...
Should Firms Tie Bonuses to Competitors’ Performance?
The Federal Reserve is pushing banks to ignore competitors' performance when awarding bonuses, and focus squarely on their own profitability, according to pay consultants and other people familiar ...
Federal Court Vacancies Could Thwart Obama’s Climate Change Agenda
President Barack Obama's plan to use federal agencies, and the Environmental Protection Agency in particular, to drive his second-term climate change agenda might be in peril if he cannot fill vacant ...Federal Court’s Damages Cap Ruling Not Binding on Mississippi’s State Courts
A Fifth Circuit Court of Appeals' decision that Mississippi's $1 million cap on non-economic damages arising from civil litigation does not violate the state constitution's separation of powers ...
Supreme Court Direction Unclear On Genetic Drug Patent Case
U.S. Supreme Court justices on Monday signaled uncertainty over how they would rule on whether brand-name drug companies can settle patent litigation with generic rivals by making deals to keep ...